Table 3 Site of recurrence
Patients experienced recurrence after PM (n = 32) | Patients experienced recurrence after SBRT (n = 18) | |
|---|---|---|
Lung alone | 11 (34%) | 6 (33%) |
Distant metastasis besides lung | 13 (41%) | 6 (33%) |
Local relapse of primary tumor or regional lymph nodes | 3 (9%) | 5 (28%) |
Local progression of PM alone | 4 (13%) | 0 (0%) |
Local progression of PM and distant metastasis | 1 (3%) | 1 (6%) |